Target intelligence / Profile preview

Hamster chymase (CMA1)

Target
CMA1
Molecular classification
Enzyme, Serine protease, Chymotrypsin-like serine protease
01

Overview

Hamster chymase is a chymotrypsin-like serine protease primarily localized within the secretory granules of mast cells. In the Syrian hamster (Mesocricetus auratus), this enzyme functions similarly to human chymase (CMA1) by serving as a major non-ACE pathway for the generation of Angiotensin II from Angiotensin I (Jin et al., 1998, PubMed: 9634404). Beyond its role in the renin-angiotensin system, it is involved in the activation of pro-fibrotic factors such as TGF-beta and the degradation of the extracellular matrix (Takai et al., 2004, PubMed: 15131263). These activities link hamster chymase to the progression of cardiac remodeling, heart failure, and various inflammatory conditions like atopic dermatitis. Because of its high functional homology to the human enzyme, hamster chymase is frequently used as a target in preclinical studies to evaluate the therapeutic potential of chymase inhibitors (He et al., 1998, PubMed: 9738411). Inhibitors such as TY-51184 and SUN-C8257 have demonstrated efficacy in reducing fibrosis and improving cardiac function in hamster models.

Other names
Chymase 1Mast cell protease 1CMA1Alpha-chymaseAngiotensin II-generating enzyme
02

Mechanism of action

Inhibition of the serine protease catalytic site to prevent the conversion of Angiotensin I to Angiotensin II and the proteolytic activation of pro-fibrotic mediators.

03

Biological functions

Angiotensin II generationExtracellular matrix remodelingInflammationProteolysisTGF-beta activation
04

Disease associations

Cardiovascular diseaseHeart failureFibrosisInflammationAtopic dermatitis
05

Safety considerations

Off-target inhibition of other serine proteasesPotential impairment of physiological wound healing
06

Interacting drugs

Chymostatin

4 more in the full profile.

07

Biomarkers

Plasma chymase activityAngiotensin II levelsMast cell density

Beyond the preview

Go deeper on Hamster chymase (CMA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hamster chymase (CMA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call